Enhancing the antiviral potency of ER &agr;‐glucosidase inhibitor IHVR‐19029 against hemorrhagic fever viruses in vitro and in vivo

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Antiviral Research

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.antiviral.2017.12.008PMID 29253498PMCID PMC5800948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterizing the selectivity of ER α-glucosidase inhibitors

  2019cited by this paper
• Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.

  2019cited by this paper
• What Does the Future Hold for Yellow Fever Virus? (I)

  2018cited by this paper
• Assessment of the potential for host‐targeted iminosugars UV‐4 and UV‐5 activity against filovirus infections in vitro and in vivo

  2017cited by this paper
• Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

  2017cited by this paper
• Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals.

  2017cited by this paper
• In vitro Susceptibility of Geographically and Temporally Distinct Zika Viruses to Favipiravir and Ribavirin

  2017influential reference
• Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication#

  2017cited by this paper
• Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies

  2017cited by this paper
• Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase Interaction.

  2017cited by this paper
• Synergistic drug combination effectively blocks Ebola virus infection

  2017cited by this paper
• Evaluation of anti‐Zika virus activities of broad‐spectrum antivirals and NIH clinical collection compounds using a cell‐based, high‐throughput screen assay

  2017cited by this paper
• Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

  2017cited by this paper
• The FDA‐approved drug sofosbuvir inhibits Zika virus infection

  2017cited by this paper
• Iminosugar antivirals: the therapeutic sweet spot

  2017cited by this paper
• Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody.

  2016cited by this paper
• The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice

  2016influential reference
• Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy.

  2016cited by this paper
• Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.

  2016cited by this paper
• Drug combination therapy increases successful drug repositioning.

  2016cited by this paper
• Approved Antiviral Drugs over the Past 50 Years

  2016cited by this paper
• A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein

  2016cited by this paper
• Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

  2016cited by this paper
• Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

  2016cited by this paper
• Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4

  2016influential reference
• Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

  2016cited by this paper
• Iminosugars: Promising therapeutics for influenza infection

  2016cited by this paper
• Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals

  2016cited by this paper
• Combating emerging viral threats

  2015cited by this paper
• In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4

  2015cited by this paper
• The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.

  2015cited by this paper
• Article Commentary: Viral Resistance of MOGS-CDG Patients Implies a Broad-Spectrum Strategy against Acute Virus Infections

  2015cited by this paper
• Dengue Virus Evolution under a Host-Targeted Antiviral

  2015cited by this paper
• Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.

  2014cited by this paper
• Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model.

  2014cited by this paper
• Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1

  2014cited by this paper
• Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

  2014cited by this paper
• Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

  2014cited by this paper
• Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever

  2014cited by this paper
• An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses

  2014cited by this paper
• Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.

  2014cited by this paper
• Membrane Topology and Function of Dengue Virus NS2A Protein

  2013cited by this paper
• Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virus.

  2013cited by this paper
• Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.

  2013influential reference
• Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents

  2013influential reference
• N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infections.

  2013cited by this paper
• Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions

  2013influential reference
• An iminosugar with potent inhibition of dengue virus infection in vivo.

  2013cited by this paper
• Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

  2013cited by this paper
• Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever

  2013cited by this paper
• Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection.

  2012cited by this paper
• RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response

  2012cited by this paper
• Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.

  2012cited by this paper
• Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.

  2011cited by this paper
• Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection.

  2011cited by this paper
• Inhibitors of Endoplasmic Reticulum α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release

  2010cited by this paper
• Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses

  2009cited by this paper
• Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.

  2009cited by this paper
• T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

  2009cited by this paper
• Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

  2008cited by this paper
• A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.

  2007cited by this paper
• Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo

  2005cited by this paper
• Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

  2003cited by this paper
• A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication.

  2003cited by this paper
• Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections

  2002cited by this paper
• Targeting glycosylation as a therapeutic approach

  2002cited by this paper
• Epitopes involved in antibody-mediated protection from Ebola virus.

  2000cited by this paper
• Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

  2000influential reference
• Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence.

  1996cited by this paper
• Analysis of combinations of antiviral drugs and design of effective multidrug therapies.

  1996cited by this paper
• The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.

  1994cited by this paper
• Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing.

  1987cited by this paper
• Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

  1987cited by this paper
• Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

  1985cited by this paper

• N-Alkyl Derivatives of Deoxynojirimycin (DNJ) as Antiviral Agents: Overview and Update

  2026cites this paper
• α-Glucosidase Inhibitors as Broad-Spectrum Antivirals: Current Knowledge and Future Prospects.

  2025cites this paper
• Borylated Five-Membered Ring Iminosugars: Synthesis, Spectroscopic Analysis, and Biological Evaluation for Glycosidase Inhibition and Anticancer Properties for Application in Boron Neutron Capture Therapy (BNCT)—Part 1

  2025cites this paper
• Therapeutic Targeting of Viral N-Glycosylation Modification: From Molecular Mechanisms to Clinical Application Prospects

  2025cites this paper
• Exploring Small-Molecule Inhibitors of Glucosidase II: Advances, Challenges, and Therapeutic Potential in Cancer and Viral Infection

  2025cites this paper
• Antiviral activity of vitamin D derivatives against severe fever with thrombocytopenia syndrome virus in vitro and in vivo

  2024cites this paper
• Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

  2024cites this paper
• Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches

  2024cites this paper
• Preparing for the next viral threat with broad-spectrum antivirals

  2023cites this paper
• A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response

  2022cites this paper
• Inhibition of Protein N-Glycosylation Blocks SARS-CoV-2 Infection

  2022cites this paper
• Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy

  2022cites this paper
• Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives

  2021cites this paper
• Bioactive Compounds from Mangrove Endophytic Fungus and Their Uses for Microorganism Control

  2021cites this paper
• Glucosidase inhibitors suppress SARS-CoV-2 in tissue culture and may potentiate

  2021cites this paper
• Contemplating Potential Chemical Therapeutic Options to Combat Marburg Virus

  2021cites this paper
• Folding and Quality Control of Glycoproteins

  2021cites this paper
• Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2

  2020cites this paper
• A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

  2020cites this paper
• Iminosugars With Endoplasmic Reticulum α-Glucosidase Inhibitor Activity Inhibit ZIKV Replication and Reverse Cytopathogenicity in vitro

  2020cites this paper
• A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing

  2020cites this paper
• Iminosugars: A host-targeted approach to combat Flaviviridae infections

  2020influential citation
• Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus

  2020cites this paper
• SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence

  2020cites this paper
• Repositioning and investigational drugs for Zika virus infection treatment: a patent review

  2020cites this paper
• COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics

  2020cites this paper
• Discovery and Mechanistic Study of a Novel Human STING Agonist

  2020cites this paper
• A new dinuclear copper (II) complex of 2,5-Furandicarboxyclic acid with 4(5)-Methylimidazole as a high potential α-glucosidase inhibitor: Synthesis, Crystal structure, Cytotoxicity study, and TD/DFT calculations

  2019cites this paper
• Developing Therapeutics for Ebola Virus Disease: A Multifaceted Approach

  2019cites this paper
• Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.

  2019cites this paper
• Characterizing the selectivity of ER α-glucosidase inhibitors

  2019cites this paper
• Two New Co(II) Complexes of Picolinate: Synthesis, Crystal Structure, Spectral Characterization, α-Glucosidase İnhibition and TD/DFT Study

  2019cites this paper
• Anti-Hepatitis C Virus Activity of Uridine Derivatives of 2-Deoxy Sugars

  2018cites this paper
• What Does the Future Hold for Yellow Fever Virus? (II)

  2018cites this paper
• What Does the Future Hold for Yellow Fever Virus? (I)

  2018cites this paper